IP Verse

Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan - EP2861210

PATENT ANALYSIS

Patent Details

Grant Date
May 3, 2017
Company
IPSEN BIOPHARM LTD.
Oppositions

TEVA PHARMACEUTICAL INDUSTRIES LTD

More patents of Ipsen Biopharm Ltd.

EP3266456

EP3337467

EP3337478

Want to monitor this patent?

Feel free to send us a message here and we will get back to you